HAEMONETICS CORP Annual Return On Equity in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Haemonetics Corp quarterly/annual Return On Equity history and growth rate from 2011 to 2023.
  • Haemonetics Corp Return On Equity for the quarter ending September 28, 2024 was 13.4 %, a 12.3% decline year-over-year.
  • Haemonetics Corp annual Return On Equity for 2023 was 15.2 %, a 5.94% decline from 2022.
  • Haemonetics Corp annual Return On Equity for 2022 was 16.2 %, a 154% increase from 2021.
  • Haemonetics Corp annual Return On Equity for 2021 was 6.36 %, a 53.2% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 15.2 -0.96 -5.94% Apr 2, 2023 Mar 30, 2024
2022 16.2 +9.8 +154% Apr 3, 2022 Apr 1, 2023
2021 6.36 -7.24 -53.2% Apr 4, 2021 Apr 2, 2022
2020 13.6 +1.99 +17.1% Mar 29, 2020 Apr 3, 2021
2019 11.6 +4.63 +66.3% Mar 31, 2019 Mar 28, 2020
2018 6.99 +0.86 +14% Apr 1, 2018 Mar 30, 2019
2017 6.13 +9.62 Apr 2, 2017 Mar 31, 2018
2016 -3.49 +3.25 +48.2% Apr 3, 2016 Apr 1, 2017
2015 -6.75 -8.84 -423% Mar 29, 2015 Apr 2, 2016
2014 2.09 -2.48 -54.3% Mar 30, 2014 Mar 28, 2015
2013 4.57 -0.92 -16.8% Mar 31, 2013 Mar 29, 2014
2012 5.49 -5.24 -48.8% Apr 1, 2012 Mar 30, 2013
2011 10.7 Apr 3, 2011 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.